{
  "url": "https://openlegislation.uk/veterinary-medicines-regulations-2013/schedule-7/paragraph-17",
  "json_url": "https://openlegislation.uk/veterinary-medicines-regulations-2013/schedule-7/paragraph-17.json",
  "legislation": "uksi/2013/2033",
  "legislation_title": "The Veterinary Medicines Regulations 2013",
  "legislation_url": "https://openlegislation.uk/veterinary-medicines-regulations-2013",
  "path": "schedule/7/paragraph/17",
  "kind": "paragraph",
  "number": "17",
  "heading": "Application for a variation to a marketing authorisation ....",
  "text": "(1) This paragraph applies in relation to an application for a variation to one or more marketing authorisations except where paragraph ... 21 applies.\n(2) The fees for the variations to which this paragraph applies are set out in the following table.\n(3) Where applications are made at the same time seeking an identical change to the terms of more than one marketing authorisation, and those applications are based on identical data, fees are payable as for a grouped variation.\n(4) References in this paragraph to a grouped variation being “led” by a particular type of variation indicate that the principal variation in that group is a variation of that type.\nType of variations\nFee (£)\nSingle variations; one change for each product\nVariation – standard\n2,895\nUnless the variation is—\n(a) a change of route of administration, or the addition of a new one, of—\n(i)\nan immunological product, or a pharmaceutical product for a non-food-producing animal\n5,390\n(ii)\na pharmaceutical product for a food-producing animal\n7,135\n(b) a change of bioavailability\n8,415\n(c) a change of active substance, where the change is to—\n(i)\nuse a different biologically active substance with a slightly different molecular structure\n8,415\n(ii)\nmodify the vector used to produce the antigen or the source material, including a new master cell bank from a different source\n8,415\n(d) a change of pharmacokinetics\n8,415\nSimultaneous application falling within (a) to (d): fee for each additional product in the application\n1,465\nVariation – reduced\n885\nVariation - no assessment\n455\nGrouped variations\nVariation – standard led\nFor the first nine changes\n6,280\nFor each subsequent group of five or fewer changes\n2,250\nVariation – reduced led:\nFor the first nine changes\n1,770\nFor each subsequent group of five or fewer changes\n2,250",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Sch. 7 para. 17(1) omitted (E.W.S.) (17.5.2024) by virtue of The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 171(a)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Sch. 7 para. 17 Table substituted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 171(b)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Words in Sch. 7 para. 17 heading omitted (E.W.S.) (31.12.2020) by virtue of The Food and Drink, Veterinary Medicines and Residues (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/865), regs. 1(2), 17(4)(i); 2020 c. 1, Sch. 5 para. 1(1)"
    },
    {
      "type": "E",
      "label": "E1",
      "text": "This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/2033/schedule/7/paragraph/17",
    "retrieved_at": "2026-10-29T00:44:44.019972+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}